18 Results for "

p38α MAP kinase

" in MedChemExpress (MCE) Product Catalog:
Products (18)

18 Results for "p38α MAP kinase" in MCE Product Catalog:

145
145 Publications Verification
Cat. No.: HY-10295
CAS No.: 152121-30-7
Purity:  99.89%
SB 202190 is a selective p38 MAP kinase inhibitor with IC50s of 50 nM and 100 nM for p38α and p38β2, respectively. SB 202190 binds to the ATP pocket of the active recombinant human p38 kinase with a Kd of 38 nM. SB 202190 has anti-cancer activity and rescued memory deficits . SB202190 induces autophagy .
loading...
    loading...
145
145 Publications Verification
Cat. No.: HY-10295A
CAS No.: 350228-36-3
Purity:  99.66%
SB 202190 hydrochloride is a selective p38 MAP kinase inhibitor with IC50s of 50 nM and 100 nM for p38α and p38β2, respectively. SB 202190 hydrochloride binds to the ATP pocket of the active recombinant human p38 kinase with a Kd of 38 nM. SB 202190 hydrochloride has anti-cancer activity . SB202190 hydrochloride induces autophagy .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-16715
CAS No.: 836683-15-9
Synonyms: BCT197
Target:  

p38 MAPK Autophagy

Research Areas:  

Inflammation/Immunology

Acumapimod (BCT197) is an orally active p38 MAP kinase inhibitor, with an IC50 of less than 1 μM for p38α.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P80776A
Synonyms: p38 (phospho T180 + Y182); p-p38 (phospho T180 + Y182); p38 (phospho T180/Y182); CSAID Binding Protein 1; CSAID binding protein; CSAID-binding protein; Csaids binding protein; CSBP 1; CSBP 2; CSBP; CSBP1; CSBP2; CSPB 1; CSPB1; Cytokine suppressive anti inflammatory drug binding protein; Cytokine suppressive anti-inflammatory drug-binding protein; EXIP; MAP kinase 14; MAP kinase MXI2; MAP kinase p38 alpha; MAPK 14; MAPK14; MAX interacting protein 2; MAX-interacting protein 2; Mitogen Activated Protein kinase 14; Mitogen activated protein kinase p38 alpha; Mitogen-activated protein kinase 14; Mitogen-activated protein kinase p38 alpha; MK14_HUMAN; Mxi 2; Mxi2; p38 ALPHA; p38; p38 MAP kinase; p38 MAPK; p38 mitogen activated protein kinase; p38ALPHA; p38alpha Exip; PRKM14; PRKM15; RK; SAPK 2A; SAPK2A; Stress Activated Protein kinase 2A.

Host:  

Rabbit

Application:  

WB, IHC-P, FC, ICC/IF, ELISA

Reactivity:  

Human, Mouse

loading...
    loading...
Cat. No.: HY-11087
CAS No.: 271576-80-8
Purity:  98.73%
Synonyms: SD-06
Target:  

p38 MAPK Autophagy

Research Areas:  

Inflammation/Immunology

SD 0006 (SD-06) is an orally active, selective, ATP-competitive and potent diaryl pyrazole inhibitor of p38α MAP kinase, with an IC50 of 110 nM for p38α .
loading...
    loading...
Cat. No.: HY-112401
CAS No.: 1638-41-1
Purity:  ≥99.0%
Target:  

p38 MAPK

Research Areas:  

Inflammation/Immunology

p38 MAP Kinase Inhibitor IV is a highly specific ATP-competitive p38α MAPK inhibitor with IC50s of 0.13 and 0.55 μM for p38α and p38β MAPK, respectively .
loading...
    loading...
Cat. No.: HY-14305
CAS No.: 623152-17-0
Target:  

p38 MAPK

Research Areas:  

Inflammation/Immunology

BMS-582949 (compound 7k) is an orally active and highly selective p38α MAP kinase inhibitor, with IC50 values of 13 nM for p38α, and 50 nM for cellular TNFα. BMS-582949 can be used for research on rheumatoid arthritis .
loading...
    loading...
Cat. No.: HY-119298
CAS No.: 905285-51-0
Target:  

p38 MAPK

Research Areas:  

Inflammation/Immunology

AW-814141 is a selective and orally active p38 MAP kinase inhibitor. AW-814141 has an IC50 values of 100 nM and 158 nM for p38-α and β isoforms, respectively. AW-814141 can inhibit the production of TNF-α induced by LPS (HY-D1056). AW-814141 can inhibit paw edema in rats in a dose-dependent manner. AW-814141 exhibits anti-inflammatory activity and can be used in the research of inflammatory diseases such as rheumatoid arthritis .
loading...
    loading...
Cat. No.: HY-105997
CAS No.: 851845-37-9
Target:  

p38 MAPK

Research Areas:  

Others

AZD 6703 is a p38α MAP kinase inhibitor with activity in inflammatory diseases.
loading...
    loading...
Cat. No.: HY-163429
CAS No.: 2883580-95-6
Research Areas:  

Inflammation/Immunology Cancer

J-1149 is a potent ALK5 inhibitor, with an IC50 value of 0.017 μM. J-1149 also shows weak p38α MAP kinase inhibitory activity, with an IC50 value of 0.435 μM. J-1149 can be used for liver fibrosis research .
loading...
    loading...
Cat. No.: HY-10295AR
CAS No.: 350228-36-3
SB 202190 (hydrochloride) (Standard) is the analytical standard of SB 202190 (hydrochloride). This product is intended for research and analytical applications. SB 202190 hydrochloride is a selective p38 MAP kinase inhibitor with IC50s of 50 nM and 100 nM for p38α and p38β2, respectively. SB 202190 hydrochloride binds to the ATP pocket of the active recombinant human p38 kinase with a Kd of 38 nM. SB 202190 hydrochloride has anti-cancer activity . SB202190 hydrochloride induces autophagy .
loading...
    loading...
Cat. No.: HY-10295R
CAS No.: 152121-30-7
SB 202190 (Standard) is the analytical standard of SB 202190. This product is intended for research and analytical applications. SB 202190 is a selective p38 MAP kinase inhibitor with IC50s of 50 nM and 100 nM for p38α and p38β2, respectively. SB 202190 binds to the ATP pocket of the active recombinant human p38 kinase with a Kd of 38 nM. SB 202190 has anti-cancer activity and rescued memory deficits . SB202190 induces autophagy .
loading...
    loading...
Cat. No.: HY-183531
CAS No.: 1228148-61-5
Target:  

p38 MAPK

Research Areas:  

Inflammation/Immunology

p38 MAP Kinase-IN-4 is a p38α MAPK inhibitor with an IC50 of 40.5 nM. p38 MAP Kinase-IN-4 is applicable to inflammation-related research .
loading...
    loading...
Cat. No.: HY-10441
CAS No.: 796069-97-1
Target:  

p38 MAPK

Research Areas:  

Cancer

BMS-626531 is a potent and selective p38α MAP kinase inhibitor. BMS-626531 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-11087R
CAS No.: 271576-80-8
Synonyms: SD-06 (Standard)
SD 0006 (Standard) is the analytical standard of SD 0006 (HY-11087). This product is intended for research and analytical applications. SD 0006 (SD-06) is an orally active, selective, ATP-competitive and potent diaryl pyrazole inhibitor of p38α MAP Kinase, with an IC50 of 110 nM for p38α .
loading...
    loading...
Cat. No.: HY-18794
CAS No.: 249936-55-8
R-03201195 is an efficient and selective p38 MAP kinase inhibitor with an IC50 for p38α of 0.7 nM. R-03201195 has inhibitory activity against TNF-α in THP-1 cells and against IL-1β in human whole blood, with IC50 values of 0.25 and 0.57 nM respectively. R-03201195 can be used for inflammatory diseases such as rheumatoid arthritis .
loading...
    loading...
Cat. No.: HY-P85712
Synonyms: Mitogen-activated protein kinase 14; MAP kinase 14; MAPK 14; Cytokine suppressive anti-inflammatory drug-binding protein; CSAID-binding protein; CSBP; MAP kinase MXI2; MAX-interacting protein 2; Mitogen-activated protein kinase p38 alpha; MAP kinase p38 alpha; Stress-activated protein kinase 2a; SAPK2a;

Host:  

Mouse

Application:  

WB, ICC/IF, ELISA

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P86460
Synonyms: Mitogen-activated protein kinase 14; MAP kinase 14; MAPK 14; Cytokine suppressive anti-inflammatory drug-binding protein; CSAID-binding protein; CSBP; MAP kinase MXI2; MAX-interacting protein 2; Mitogen-activated protein kinase p38 alpha; MAP kinase p38 alpha; Stress-activated protein kinase 2a; SAPK2a;

Host:  

Rabbit

Application:  

WB, ICC/IF, IP, ELISA

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
  • 1